Company attributes
Other attributes
Janssen Pharmaceuticals develops treatment for patients worldwide in the following therapeutic areas of healthcare: Cardiovascular & Metabolism , Immunology , Infectious Diseases & Vaccines , Neuroscience , Oncology and Pulmonary Hypertension. Janssen partners with academic researchers, governments, patient groups, healthcare professionals, and others in their research. Janssen's activities range from initial basic research and production to commercial and support services and sale of medicines. Janssen Pharmaceutica operates as a subsidiary of Johnson & Johnson.
Janssen Pharmaceutica has been working with its parent company to create a medicine to aid with the COVID-19 pandemic. It is using non-replicating viral vector as well as Ad26 (alone or with modified vaccina Ankara boost) technology to conduct studies on how the vaccine can be used in the pandemic.